Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng

被引:282
作者
Kim, Dong-Hyun [1 ,2 ]
机构
[1] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea
[2] Kyung Hee Univ, Dept Pharmaceut Sci, Seoul 130701, South Korea
关键词
Panax ginseng; Panax quinquifolium; Panax notoginseng; Constituents; Biotransformation; DAMMARANE-TYPE SAPONINS; ALPHA-L-ARABINOFURANOSIDASE; HUMAN INTESTINAL BACTERIA; CHINESE CRUDE DRUGS; KINASE-A PATHWAY; AMERICAN GINSENG; COMPOUND-K; FLOWER-BUDS; HYPOGLYCEMIC ACTIVITY; TRITERPENE SAPONINS;
D O I
10.5142/jgr.2012.36.1.1
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The major commercial ginsengs are Panax ginseng Meyer (Korean ginseng), P quinquifolium L. (American ginseng), and P notoginseng (Burk.) Chen (Notoginseng). P ginseng is the most commonly used as an adaptogenic agent and has been shown to enhance physical performance, promote vitality, increase resistance to stress and aging, and have immunomodulatory activity. These ginsengs contain saponins, which can be classified as dammarane-type, ocotillol-type and oleanane-type oligoglycosides, and polysaccharides as main constituents. Dammarane ginsenosides are transformed into compounds such as the ginsenosides Rg(3), Rg(5), and Rk(1), by steaming and heating and are metabolized into metabolites such as compound K, ginsenoside Rh-1, proto- and panaxatriol by intestinal microflora. These metabolites are nonpolar, pharmacologically active and easily absorbed from the gastrointestinal tract. However, the activities metabolizing these constituents into bioactive compounds differ significantly among individuals because all individuals possess characteristic indigenous strains of intestinal bacteria. To overcome this difference, ginsengs fermented with enzymes or microbes have been developed.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 150 条
[41]   Biotransformation of Korean Panax ginseng by Pectinex [J].
Kim, Bo-Hye ;
Lee, Sun-Yi ;
Cho, Hyo-Jin ;
you, Sun-Nng You ;
Kim, Yeong-Jin ;
Park, Yeong-Min ;
Lee, Jae-Kwon ;
Baik, Moo-Yeol ;
Park, Cheon-Seok ;
Ahn, Soon-Cheol .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (12) :2472-2478
[42]  
Kim DH, 2003, BIOL PHARM BULL, V26, P1035, DOI 10.1248/bpb.26.1035
[43]  
Kim Dong-Hyun, 2009, Journal of Ginseng Research, V33, P165
[44]  
Kim DongHyun Kim DongHyun, 2002, Natural Product Sciences, V8, P35
[45]   PANAX GINSENG AS A POTENTIAL IMMUNOMODULATOR - STUDIES IN MICE [J].
KIM, JY ;
GERMOLEC, DR ;
LUSTER, MI .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1990, 12 (02) :257-276
[46]  
Kim SJ, 2007, J MICROBIOL BIOTECHN, V17, P905
[47]   CHEMICAL STUDIES ON CRUDE DRUG PRECESSION .1. ON THE CONSTITUENTS OF GINSENG RADIX RUBRA [J].
KITAGAWA, I ;
YOSHIKAWA, M ;
YOSHIHARA, M ;
HAYASHI, T ;
TANIYAMA, T .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1983, 103 (06) :612-622
[48]   CHEMICAL STUDIES ON CRUDE DRUG PROCESSING .5. ON THE CONSTITUENTS OF GINSENG RADIX RUBRA-(2) COMPARISON OF THE CONSTITUENTS OF WHITE GINSENG AND RED GINSENG PREPARED FROM THE SAME PANAX-GINSENG ROOT [J].
KITAGAWA, I ;
TANIYAMA, T ;
SHIBUYA, H ;
NODA, T ;
YOSHIKAWA, M .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1987, 107 (07) :495-505
[49]   Enzymatic preparation of ginsenosides Rg2, Rh1, and F11) [J].
Ko, SR ;
Choi, KJ ;
Suzuki, K ;
Suzuki, Y .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (04) :404-408
[50]   Enzymatic preparation of minor saponins and intestinal bacterial saponin metabolites of ginseng.: Part III.: Marked production of ginsenosides Rd, F2, Rg3, and compound K by enzymatic Method [J].
Ko, Sung-Ryong ;
Suzuki, Yukio ;
Suzuki, Kei ;
Choi, Kang-Ju ;
Cho, Byung-Goo .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2007, 55 (10) :1522-1527